Cervical Cancer Clinical Trials in Rio de Janeiro, Rio de Janeiro
2 recruitingRio de Janeiro, Rio de Janeiro, Brazil
Showing 1–2 of 2 trials
Recruiting
Phase 2
Low-dose Pembrolizumab Plus Chemotherapy for the First-Line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer.
Persistent, Recurrent, or Metastatic Cervical Cancer
Instituto Nacional de Cancer, Brazil44 enrolled1 locationNCT06670911
Recruiting
Phase 3
Adjuvant Chemotherapy in cfHPV-DNA Plasma Positive Patients: A Biomarker In Locally Advanced Cervical Cancer
Cervical CancerCervix CancerCervix Neoplasm
Hospital do Coracao365 enrolled26 locationsNCT05764044